Concepedia

Institute for Rare and Neglected Diseases Drug Discovery

IF

Statistics

Publications

42

Citations

1.3K

Authors

1

Location

Mountain View, United States

Also known as iRND3

Institute for Rare and Neglected Diseases Drug Discovery is a nonprofit institution in Mountain View, United States known for pharmacology, drug discovery, and molecular pharmacology.

HomepageROR

Top concepts

Publications

42

Phenotypic vs. Target-Based Drug Discovery for First-in-Class Medicines

David C. Swinney · Clinical Pharmacology & Therapeutics · 2013 · 412 citations

, , +8

Transcriptomic analysis of the woodchuck model of chronic hepatitis B

Simon P. Fletcher, Daniel J. Chin, Yongmei Ji et al. · Hepatology · 2012 · 100 citations

, , +17

The Contribution of Mechanistic Understanding to Phenotypic Screening for First-in-Class Medicines

David C. Swinney · SLAS DISCOVERY · 2013 · 70 citations · Full text

, , +11

A study of the molecular mechanism of binding kinetics and long residence times of human <scp>CCR</scp>5 receptor small molecule allosteric ligands

David C. Swinney, Paul A. Beavis, Kai‐Ting Chuang et al. · British Journal of Pharmacology · 2014 · 64 citations · Full text

, , +17

Collaboration for rare disease drug discovery research

Nadia K. Litterman, Michele Rhee, David C. Swinney et al. · F1000Research · 2014 · 28 citations · Full text

, , +15

1–5 of 42

Authors

1

  1. PR
    Palani Ravendran

    Institute for Rare and Neglected Diseases Drug Discovery, United States

    1 publications · 64 citations

    1

    h-index

1–1 of 1